Literature DB >> 23897467

Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.

Areej Abuhammad1, Edward D Lowe, Michael A McDonough, Patrick D Shaw Stewart, Stefan A Kolek, Edith Sim, Elspeth F Garman.   

Abstract

Arylamine N-acetyltransferase from Mycobacterium tuberculosis (TBNAT) plays an important role in the intracellular survival of the microorganism inside macrophages. Medicinal chemistry efforts to optimize inhibitors of the TBNAT enzyme have been hampered by the lack of a three-dimensional structure of the enzyme. In this paper, the first structure of TBNAT, determined using a lone crystal produced using cross-seeding with the homologous protein from M. marinum, is reported. Despite the similarity between the two enzymes (74% sequence identity), they show distinct physical and biochemical characteristics. The structure elegantly reveals the characteristic features of the protein surface as well as details of the active site of TBNAT relevant to drug-discovery efforts. The crystallographic analysis of the diffraction data presented many challenges, since the crystal was twinned and the habit possessed pseudo-translational symmetry.

Entities:  

Keywords:  arylamine N-acetyltransferase; cholesterol catabolism; cross-seeding; crystal microseeding; drug targets; microseed matrix screen; pseudo-translational symmetry; tuberculosis; twinning

Mesh:

Substances:

Year:  2013        PMID: 23897467     DOI: 10.1107/S0907444913015126

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  11 in total

1.  Microseed matrix screening for optimization in protein crystallization: what have we learned?

Authors:  Allan D'Arcy; Terese Bergfors; Sandra W Cowan-Jacob; May Marsh
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-08-29       Impact factor: 1.056

2.  A novel microseeding method for the crystallization of membrane proteins in lipidic cubic phase.

Authors:  Stefan Andrew Kolek; Bastian Bräuning; Patrick Douglas Shaw Stewart
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-03-24       Impact factor: 1.056

3.  X-ray transparent microfluidic platforms for membrane protein crystallization with microseeds.

Authors:  Jeremy M Schieferstein; Ashtamurthy S Pawate; Michael J Varel; Sudipto Guha; Ieva Astrauskaite; Robert B Gennis; Paul J A Kenis
Journal:  Lab Chip       Date:  2018-03-13       Impact factor: 6.799

4.  The actinobacterium Tsukamurella paurometabola has a functionally divergent arylamine N-acetyltransferase (NAT) homolog.

Authors:  Vasiliki Garefalaki; Evanthia Kontomina; Charalambos Ioannidis; Olga Savvidou; Christina Vagena-Pantoula; Maria-Giusy Papavergi; Ioannis Olbasalis; Dionysios Patriarcheas; Konstantina C Fylaktakidou; Tamás Felföldi; Károly Márialigeti; Giannoulis Fakis; Sotiria Boukouvala
Journal:  World J Microbiol Biotechnol       Date:  2019-10-31       Impact factor: 3.312

Review 5.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

6.  Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.

Authors:  Nicola Laurieri; Akane Kawamura; Isaac M Westwood; Amy Varney; Elizabeth Morris; Angela J Russell; Lesley A Stanley; Edith Sim
Journal:  BMC Pharmacol Toxicol       Date:  2014-11-29       Impact factor: 2.483

7.  The Role of N-Acetyl Transferases on Isoniazid Resistance from Mycobacterium tuberculosis and Human: An In Silico Approach.

Authors:  Ameeruddin Nusrath Unissa; Swathi Sukumar; Luke Elizabeth Hanna
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-07-03

8.  Comparative Investigation of 15 Xenobiotic-Metabolizing N-Acetyltransferase (NAT) Homologs from Bacteria.

Authors:  Vasiliki Garefalaki; Maria-Giusy Papavergi; Olga Savvidou; Georgia Papanikolaou; Tamás Felföldi; Károly Márialigeti; Giannoulis Fakis; Sotiria Boukouvala
Journal:  Appl Environ Microbiol       Date:  2021-09-10       Impact factor: 4.792

Review 9.  Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.

Authors:  E Sim; A Abuhammad; A Ryan
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Exploration of piperidinols as potential antitubercular agents.

Authors:  Areej Abuhammad; Elizabeth Fullam; Sanjib Bhakta; Angela J Russell; Garrett M Morris; Paul W Finn; Edith Sim
Journal:  Molecules       Date:  2014-10-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.